Document is current
Any future updates will be listed below
-
Authors
Goodsell, Kristin E.
Sham, Jonathan G.
- License Information
-
More Information
Article History
Received: 4 June 2025
Accepted: 4 June 2025
First Online: 23 June 2025
Disclosure
: Dr. Jonathan G. Sham is Study Chair of S2408, a NCTN-based multicenter randomized trial of lanreotide for the prevention of postoperative pancreatic fistula. This study was sponsored by SWOG, and Dr. Sham received no compensation from SWOG or Cipla pharmaceuticals, which provide drug for the study.
